Chronic inflammation is a harmful and ongoing response by the immune system that can lead to serious health problems, including Alzheimer’s, Parkinson’s, diabetes, and cancer. Unlike acute inflammation, which helps the body heal from injury or infection, chronic inflammation persists and causes damage over time.

Factors like aging, stress, and exposure to environmental toxins can keep the immune system in a constant state of alert, eventually harming healthy tissues and organs.

Scientists at the University of California, Berkeley, have made a significant discovery that could change how we treat chronic inflammation. They have identified a molecular “switch” that can turn off the processes responsible for this harmful condition.

This finding, led by researcher Danica Chen and published in the journal Cell Metabolism, offers new hope for preventing and possibly reversing many age-related diseases.

At the center of this discovery is a group of immune proteins called the NLRP3 inflammasome. This inflammasome acts like a sentry, detecting potential threats and triggering inflammation to protect the body.

While this system is helpful in short-term situations like infections, problems arise when it becomes overactive. An overactive NLRP3 inflammasome contributes to chronic inflammation, playing a role in diseases like multiple sclerosis, cancer, diabetes, and dementia.

The study revealed that the NLRP3 inflammasome can be deactivated through a process called deacetylation. This process removes a small molecular fragment from the inflammasome, effectively switching it off.

A protein called SIRT2 is responsible for this deactivation. When SIRT2 removes the fragment, it stops the inflammasome from causing unnecessary inflammation.

To test this, researchers conducted experiments on mice. They found that mice lacking SIRT2 showed higher levels of inflammation as they aged.

By the age of two, these mice had more severe inflammation and greater insulin resistance—a condition that often leads to type 2 diabetes and other metabolic issues—compared to normal mice.

In another part of the study, researchers worked with older mice whose immune systems were rebuilt using specially modified blood stem cells. These cells were designed to produce either the active (acetylated) or inactive (deacetylated) form of the NLRP3 inflammasome.

Mice with the inactive form showed significant improvements in insulin resistance after just six weeks, suggesting that deactivating the inflammasome might not only prevent chronic inflammation but also reverse some of its harmful effects.

The implications of this discovery are profound. If scientists can develop drugs to target this molecular switch and deactivate the NLRP3 inflammasome, it could lead to new treatments for many chronic conditions.

Diseases like Alzheimer’s, which have proven difficult to treat, might benefit from earlier interventions targeting inflammation before irreversible damage occurs.

This research also highlights the broader importance of managing chronic inflammation to protect against various health issues. It opens doors to new therapies that could improve quality of life as people age, keeping the immune system balanced and preventing it from harming the body.

For individuals interested in maintaining health and longevity, the study serves as a reminder of the complex links between inflammation, diet, and overall well-being. Other recent research has shown that certain diets might negatively affect bone health, while compounds in cannabis could potentially protect the brain from aging.

Additionally, common food oils in the U.S. have been found to alter brain genes, emphasizing how lifestyle factors influence inflammation and chronic disease.

The discovery of this molecular switch marks a promising step forward. By addressing the root causes of chronic inflammation, scientists may be able to create treatments that not only manage symptoms but also enhance overall health and extend lifespans.

This breakthrough brings hope for a future where age-related diseases can be more effectively controlled, allowing for healthier, longer lives.

If you care about inflammation, please read studies about the big cause of inflammation in common bowel disease, and vitamin B may help fight COVID-19 and reduce inflammation.

For more health information, please see recent studies about new way to halt excessive inflammation, and results showing foods that could cause inflammation.

Copyright © 2025 Knowridge Science Report. All rights reserved.